New therapeutic possibilities and clinical implications of neonatal alloimmune thrombocytopenia
- Prosjektnummer
- SFP941-10
- Ansvarlig person
- Bjørn Skogen
- Institusjon
- Universitetssykehuset Nord-Norge HF
- Prosjektkategori
- Korttidsstipend, for fullføring av dr. grad
- Helsekategori
- Inflammatory and immune system
- Forskningsaktivitet
- 3. Prevention
Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention.
Expert Rev Hematol 2010 Oct;3(5):559-66.
PMID: 21083473
Quantitative MAIPA: Comparison of different MAIPA protocols.
Transfus Apher Sci 2010 Oct;43(2):149-54. Epub 2010 aug 2
PMID: 20675194
A high affinity monoclonal anti-HPA 1a antibody derived from memory B cells of a woman alloimmunized in connection with pregnanc
Vox Sang. 2010, 99 (S2),13.
Prophylactic administration of anti-beta3 antibodies induced antibody mediated immune suppression (AMIS) and prevented severe cl
Vox Sang. 2010, 99 (S2),13.
Platelet antibodies and fetal growth: maternal HPA-1a alloimmunization is strongly associated with reduced birth weight.
Vox Sang. 2010, 99 (S2), 21.
Blood group antigens and immune responses-detailed knowledge is necessary to prevent immunization and to follow up immunized ind
ISBT Science Series; 2010, 5, 24-26.
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport, Helse Nord